ch.oddb.org
 
Apotheken | Arzt | Interaktionen | Medikamente | MiGeL | Services | Spital | Zulassungsi.
Fachinformation zu NuvaRing® mit Applikator:Organon GmbH
Vollst. FachinformationDDDÄnderungen anzeigenDrucken 
Zusammens.Galen.FormInd./Anw.mögl.Dos./Anw.Kontraind.Warn.hinw.Interakt.Schwangerschaft
Fahrtücht.Unerw.WirkungenÜberdos.Eigensch.Pharm.kinetikPräklin.Sonstige H.Swissmedic-Nr.
PackungenReg.InhaberStand d. Info. 
G02BB01 - Vaginal Ring with Progestogen and EstrogenATC-DDD Version 2016. Source: WHO
G - Genito Urinary System and Sex Hormones
 
G02 - Other Gynecologicals

Analgesics used in dysmenorrhea, see N02B - Other analgesics and antipyretics and M01A - Antiinflammatory and antirheumatic products, non-steroids.

G02B - Contraceptives for Topical Use

Contraceptives for systemic use, see G03A.

G02BB - Intravaginal Contraceptives

Pessaries, vaginal foams etc. are classified in this group.
Intravaginal devices containing hormones are also classified in this group.

The DDDs for combined devices containing estrogen and progestogen are based on use in menstrual cycles of 28 days. Thus the DDD is 0.0357 UD (1 UD = 1 device).

G02BB01 - Vaginal Ring with Progestogen and Estrogen
2024 ©ywesee GmbH
Einstellungen | Hilfe | FAQ | Anmeldung | Kontakt | Home